NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

VEEV

Veeva Systems Inc

Apr 28 • 04:00PM ET

225.77

Dollar change -1.77
Percentage change -0.78	%

Healthcare • Health Information Services • USA • NYSE

Peers: CRM ADBE ORCL WDAY MCK NOW TEAM HUBS OKTA ZS

| Held by: VTI VO VXF VUG MOAT VOT IWP IWF IWR VHT

Scroll to Statements

Index	-	P/E	52.14	EPS (ttm)	4.33	Insider Own	8.63%	Shs Outstand	162.58M	Perf Week	7.47%
Market Cap	36.73B	Forward P/E	27.95	EPS next Y	8.08	Insider Trans	-0.06%	Shs Float	148.67M	Perf Month	-4.93%
Income	714.14M	PEG	4.50	EPS next Q	1.74	Inst Own	80.53%	Short Float	2.62%	Perf Quarter	0.00%
Sales	2.75B	P/S	13.37	EPS this Y	10.66%	Inst Trans	1.59%	Short Ratio	3.09	Perf Half Y	3.69%
Book/sh	35.87	P/B	6.29	EPS next Y	10.61%	ROA	10.78%	Short Interest	3.89M	Perf Year	12.59%
Cash/sh	31.66	P/C	7.13	EPS next 5Y	11.59%	ROE	13.63%	52W Range	170.25 - 258.93	Perf YTD	7.38%
Dividend Est.	-	P/FCF	34.34	EPS past 5Y	17.84%	ROI	12.11%	52W High	-12.81%	Beta	0.97
Dividend TTM	-	Quick Ratio	4.51	Sales past 5Y	20.27%	Gross Margin	74.53%	52W Low	32.61%	ATR (14)	7.80
Dividend Ex-Date	-	Current Ratio	4.51	EPS Y/Y TTM	34.71%	Oper. Margin	25.17%	RSI (14)	52.30	Volatility	2.60% 3.72%
Employees	7291	Debt/Eq	0.01	Sales Y/Y TTM	16.20%	Profit Margin	26.00%	Recom	2.03	Target Price	263.52
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	31.43%	Payout	0.00%	Rel Volume	0.89	Prev Close	227.54
Sales Surprise	3.10%	EPS Surprise	8.84%	Sales Q/Q	14.31%	Earnings	Mar 05 AMC	Avg Volume	1.26M	Price	225.77
SMA20	2.59%	SMA50	-0.53%	SMA200	4.21%	Trades		Volume	1,121,862	Change	-0.78%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-23-25	Downgrade	Goldman	Buy → Sell	$261 → $200
Dec-20-24	Initiated	Stephens	Overweight	$280
Dec-04-24	Initiated	Mizuho	Outperform	$275
Nov-19-24	Initiated	Scotiabank	Sector Perform	$235
Oct-08-24	Initiated	Exane BNP Paribas	Outperform	$286
Aug-27-24	Reiterated	Citigroup	Buy	$256 → $273
Jul-09-24	Initiated	BTIG Research	Buy	$240
Oct-25-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$211 → $229
Oct-13-23	Initiated	Jefferies	Buy	$265
Jun-28-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$181
Jun-01-23	Upgrade	Guggenheim	Neutral → Buy	$226
Mar-17-23	Downgrade	Truist	Buy → Hold	$205 → $195
Feb-23-23	Downgrade	Guggenheim	Buy → Neutral
Jan-04-23	Upgrade	Barclays	Equal Weight → Overweight	$205
Dec-06-22	Initiated	Cowen	Market Perform	$184
Dec-02-22	Reiterated	Needham	Buy	$205 → $220
Oct-31-22	Initiated	Wells Fargo	Equal Weight	$180
Oct-19-22	Upgrade	JP Morgan	Underweight → Neutral	$225 → $170
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$220
Jul-27-22	Initiated	Oppenheimer	Outperform	$250

Show Previous Ratings

Today 09:19AM	HSIC Gears Up for Q1 Earnings: Here's What You Need to Know (Zacks)
Apr-25-25 05:45PM	Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors (Zacks)
10:18AM	CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
Apr-24-25 01:02PM	Here's Why You Should Add Veeva Stock to Your Portfolio Now (Zacks)
10:42AM	Penumbra Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Expand (Zacks)
07:25AM	Loading…
07:25AM	AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise (Zacks)
07:24AM	ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market (Zacks)
06:43AM	EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View Raised (Zacks)
01:15AM	Artisan Mid Cap Fund Q1 2025 Commentary (Seeking Alpha)
Apr-23-25 12:53PM	Thermo Fisher's Q1 Earnings Top Estimates, Revenues Beat, Stock Up (Zacks)
09:47AM	BSX Q1 Earnings & Revenues Beat, Stock Up, 2025 View Raised (Zacks)
Apr-22-25 11:34AM	Concentra Stock Slips Despite Deal to Acquire Pivot Onsite Innovations (Zacks)
11:30AM	BD Stock Down Despite Monitoring Platform Launch to Boost Patient Care (Zacks)
10:34AM	Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up (Zacks)
08:39AM	Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network (Zacks)
08:13AM	Loading…
08:13AM	Zimmer Biomet to Report Q1 Earnings: Here's What to Expect (Zacks)
Apr-21-25 11:08AM	ECL Stock Gains Following 5% Trade Surcharge in the United States (Zacks)
09:57AM	Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results? (Zacks)
08:34AM	IDXX Gears Up for Q1 Earnings: What to Expect From the Stock? (Zacks)
05:38AM	3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era (Zacks)
Apr-18-25 09:30AM	Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy? (Zacks)
06:30AM	Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next (Motley Fool)
Apr-17-25 11:52AM	Veeva Systems: Substantially Overvalued As Growth Slows (Seeking Alpha)
09:00AM	Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock (Zacks)
08:53AM	ALGN Gears Up for Q1 Earnings: What Lies Ahead for the Stock? (Zacks)
08:31AM	Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings (Zacks)
Apr-16-25 01:07PM	Abbott Q1 Earnings Beat, Sales Miss, Stock Falls in Pre-Market (Zacks)
10:40AM	CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm (Zacks)
10:17AM	Labcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth (Zacks)
09:21AM	Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now (Zacks)
07:32AM	Loading…
07:32AM	Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings (Zacks)
07:13AM	LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7 (Zacks)
07:10AM	Here's Why You Should Retain Inogen Stock in Your Portfolio Now (Zacks)
05:10AM	Q4 Earnings Outperformers: Veeva Systems (NYSE:VEEV) And The Rest Of The Vertical Software Stocks (StockStory)
Apr-15-25 05:50PM	Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
11:20AM	HealthEquity Stock Plunges 13% YTD: Is It Time to Exit or Hold? (Zacks)
11:04AM	Merit Medical Stock Slips Despite the Launch of New Ventrax System (Zacks)
09:28AM	Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings (Zacks)
Apr-14-25 09:39AM	Intuitive Surgical Shares May Rise as FDA Clears SureForm 45 Stapler (Zacks)
Apr-11-25 01:01PM	DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance (Zacks)
12:15PM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Apr-10-25 11:38AM	Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? (Zacks)
07:29AM	Neogen Stock Tumbles on Q3 Earnings & Sales Miss, Margins Contract (Zacks)
Apr-09-25 07:26AM	Walgreens Beats on Q2 Earnings, Withdraws Fiscal 2025 View, Stock Down (Zacks)
Apr-08-25 06:20AM	Is WisdomTree Cloud Computing ETF (WCLD) a Strong ETF Right Now? (Zacks)
Apr-07-25 05:50PM	Veeva Systems (VEEV) Gains As Market Dips: What You Should Know (Zacks)
Apr-06-25 08:00AM	2 Top Growth Stocks to Buy and Hold for the Next 20 Years (Motley Fool)
Apr-04-25 11:30AM	Why Is Veeva (VEEV) Down 6.2% Since Last Earnings Report? (Zacks)
08:44AM	Veeva Systems (VEEV) Benefited in Q4 From Strong Execution (Insider Monkey)
Apr-03-25 06:39PM	Analyst Report: Veeva Systems Inc. (Morningstar Research)
04:50PM	Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday (Motley Fool)
09:00AM	The Zacks Rank Explained: How to Find Strong Buy Medical Stocks (Zacks)
06:40AM	New Strong Buy Stocks for April 3rd (Zacks)
03:47AM	Best Momentum Stocks to Buy for April 3rd (Zacks)
Apr-02-25 10:10AM	VEEV Stock Slips Despite New Research Site Clinical Trial System (Zacks)
09:30AM	Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It? (Zacks)
09:00AM	Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Apr-01-25 08:19AM	5 Momentum Stocks to Buy for April Despite a Disappointing March (Zacks)
07:03AM	Veeva Announces Research Site Clinical Trial Management System (PR Newswire)
Mar-31-25 04:21PM	Top Stock Picks for Week of March 31, 2025 (Zacks)
Mar-28-25 04:00PM	China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market (Investor's Business Daily)
01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-27-25 10:50AM	Columbia Select Large Cap Growth Fund Q4 2024 Commentary (SeekingAlpha)
Mar-25-25 08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
08:30AM	Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth Today (Zacks)
Mar-24-25 09:02AM	2 High-Flying Stocks to Target This Week and 1 to Brush Off (StockStory)
06:20AM	Should You Invest in the WisdomTree Cloud Computing ETF (WCLD)? (Zacks)
Mar-20-25 04:13PM	Stock Market Today: Dow Jones Dips As Nvidia Eyes Opportunity; Warren Buffett Stock Hits New High (Live Coverage) (Investor's Business Daily)
12:14PM	Stock Market Today: Stock Market News And Analysis (Investor's Business Daily)
Mar-19-25 09:00AM	Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:03AM	Indero Marks 40th Study Live with Veeva RTSM (PR Newswire)
Mar-18-25 09:03AM	2 Large-Cap Stocks with Exciting Potential and 1 to Avoid (StockStory)
Mar-17-25 09:30AM	Veeva (VEEV) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
Mar-11-25 12:00PM	Veeva (VEEV) Upgraded to Strong Buy: Here's Why (Zacks)
09:48AM	Veeva Systems Inc. (VEEV): A Bull Case Theory (Insider Monkey)
07:03AM	Boehringer Ingelheim Partners with Veeva to Launch 'One Medicine Platform' (PR Newswire)
Mar-07-25 07:03PM	Analyst Report: Veeva Systems Inc. (Morningstar Research)
10:01AM	Veeva price target raised to $245 from $240 at Scotiabank (TipRanks)
Mar-06-25 04:45PM	Stock Market Today: Nasdaq Falls 2.6% In Broad Sell-Off, But S&P 500 Holds Above This Important Level; McDonald's Sets Up Potential Breakout (Live Coverage) (Investor's Business Daily) +7.37%
02:29PM	Why Veeva Systems (VEEV) Is Rallying Today (Insider Monkey)
01:38PM	Veeva Systems (VEEV) Stock Trades Up, Here Is Why (StockStory)
12:56PM	Why Veeva Systems Stock Is Surging Today (Motley Fool)
10:30AM	Q4 2025 Veeva Systems Inc Earnings Call (Thomson Reuters StreetEvents)
09:57AM	Analyst Report: Veeva Systems Inc. (Morningstar Research)
09:38AM	Stocks to Watch Thursday: Alibaba, Broadcom, Macy's, Kroger (The Wall Street Journal)
02:11AM	Veeva Systems Inc (VEEV) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Mar-05-25 11:30PM	Veeva Systems (VEEV) Q4 2025 Earnings Call Transcript (Motley Fool)
06:00PM	Veeva (VEEV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	Veeva Systems (VEEV) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:27PM	Veeva: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:26PM	Veeva Systems (NYSE:VEEV) Beats Q4 Sales Targets, Stock Soars (StockStory)
04:05PM	Veeva Announces Fourth Quarter and Fiscal Year 2025 Results (PR Newswire)
12:00AM	Veeva CRM Pulse Improves Segmentation and Targeting with Brick-Level HCP Access Data for 21 Countries (PR Newswire)
Mar-04-25 09:18PM	Veeva CRM Pulse Improves Segmentation and Targeting with Brick-Level HCP Access Data for 21 Countries (PR Newswire)
03:05PM	Jim Cramer Believes Veeva Systems Inc. (VEEV) Is Facing Tough Competition (Insider Monkey)
08:04AM	Veeva Systems (VEEV) Reports Earnings Tomorrow: What To Expect (StockStory)
07:03AM	Veeva Commercial Pulse Improves Segmentation and Targeting with Brick-Level HCP Access Data for 21 Countries (PR Newswire)
Mar-03-25 07:03AM	Top Global Biopharmas Standardize on Veeva China CRM Suite (PR Newswire)
Feb-28-25 05:45PM	Veeva Systems (VEEV) Ascends But Remains Behind Market: Some Facts to Note (Zacks)

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schwenger Thomas D.	Pres. & Chief Customer Officer	Apr 14 '25	Sale	220.97	1,200	265,168	25,889	Apr 15 04:49 PM
Schwenger Thomas D.	Officer	Apr 10 '25	Proposed Sale	223.29	4,950	1,105,300		Apr 10 11:03 AM
Cabral Timothy S	Director	Apr 04 '25	Sale	216.83	3,882	841,734	5,500	Apr 08 04:55 PM
Cabral Timothy S	Director	Apr 04 '25	Proposed Sale	216.77	3,882	841,482		Apr 04 02:10 PM
Zuppas Eleni Nitsa	President & Chief of Staff	Apr 01 '25	Option Exercise	0.00	1,324	0	24,103	Apr 02 05:50 PM
Van Wagener Brian	Chief Financial Officer	Apr 01 '25	Option Exercise	0.00	823	0	6,393	Apr 02 05:49 PM
Schwenger Thomas D.	Pres. & Chief Customer Officer	Apr 01 '25	Option Exercise	0.00	1,909	0	30,238	Apr 02 05:48 PM
Faddis Jonathan	SVP, Gen. Counsel, Secretary	Apr 01 '25	Option Exercise	0.00	1,120	0	9,856	Apr 02 05:46 PM
Faddis Jonathan	SVP, Gen. Counsel, Secretary	Apr 02 '25	Sale	226.20	787	178,019	8,668	Apr 02 05:46 PM
DIAMOND KRISTINE	Chief Accounting Officer	Apr 01 '25	Option Exercise	0.00	204	0	942	Apr 02 05:45 PM
Faddis Jonathan	Officer	Apr 02 '25	Proposed Sale	226.20	787	178,019		Apr 02 04:12 PM
Carges Mark T	Director	Mar 01 '25	Option Exercise	0.00	356	0	356	Mar 03 07:17 PM
Cabral Timothy S	Director	Mar 01 '25	Option Exercise	0.00	314	0	314	Mar 03 07:16 PM
Hedley Mary Lynne	Director	Mar 01 '25	Option Exercise	0.00	342	0	5,760	Mar 03 07:15 PM
Hung Priscilla	Director	Mar 01 '25	Option Exercise	0.00	342	0	3,966	Mar 03 07:14 PM
Hunt Nimrata	Director	Mar 01 '25	Option Exercise	0.00	342	0	3,859	Mar 03 07:13 PM
MOHR MARSHALL	Director	Mar 01 '25	Option Exercise	0.00	384	0	4,436	Mar 03 07:12 PM
Ritter Gordon	Director	Mar 01 '25	Option Exercise	0.00	398	0	398	Mar 03 07:11 PM
SEKHRI PAUL J	Director	Mar 01 '25	Option Exercise	0.00	328	0	16,340	Mar 03 07:10 PM
Wallach Matthew J	Director	Mar 01 '25	Option Exercise	0.00	328	0	105,591	Mar 03 07:08 PM
Van Wagener Brian	Chief Financial Officer	Jan 01 '25	Option Exercise	0.00	1,370	0	6,047	Jan 03 05:10 PM
Schwenger Thomas D.	Pres. & Chief Customer Officer	Jan 01 '25	Option Exercise	0.00	1,909	0	28,922	Jan 03 05:09 PM
DIAMOND KRISTINE	Chief Accounting Officer	Jan 01 '25	Option Exercise	0.00	203	0	822	Jan 03 05:08 PM
Zuppas Eleni Nitsa	President & Chief of Staff	Jan 01 '25	Option Exercise	0.00	1,323	0	23,296	Jan 03 05:07 PM
Faddis Jonathan	SVP, Gen. Counsel, Secretary	Jan 01 '25	Option Exercise	0.00	1,120	0	9,181	Jan 03 05:05 PM
Faddis Jonathan	SVP, Gen. Counsel, Secretary	Dec 04 '24	Sale	230.30	1,694	390,128	8,061	Dec 06 04:17 PM
Faddis Jonathan	Officer	Dec 04 '24	Proposed Sale	230.30	1,694	390,128		Dec 04 04:18 PM
Cabral Timothy S	Director	Dec 01 '24	Option Exercise	0.00	315	0	1,741	Dec 02 05:02 PM
Hedley Mary Lynne	Director	Dec 01 '24	Option Exercise	0.00	343	0	5,418	Dec 02 05:01 PM
Hung Priscilla	Director	Dec 01 '24	Option Exercise	0.00	343	0	3,624	Dec 02 05:01 PM
Wallach Matthew J	Director	Dec 01 '24	Option Exercise	0.00	329	0	105,263	Dec 02 05:00 PM
SEKHRI PAUL J	Director	Dec 01 '24	Option Exercise	0.00	329	0	16,012	Dec 02 04:59 PM
Ritter Gordon	Director	Dec 01 '24	Option Exercise	0.00	399	0	1,501	Dec 02 04:59 PM
MOHR MARSHALL	Director	Dec 01 '24	Option Exercise	0.00	385	0	4,052	Dec 02 04:58 PM
Hunt Nimrata	Director	Dec 01 '24	Option Exercise	0.00	343	0	3,517	Dec 02 04:57 PM
Carges Mark T	Director	Dec 01 '24	Option Exercise	0.00	357	0	357	Dec 02 04:57 PM
Schwenger Thomas D.	Pres. & Chief Customer Officer	Nov 08 '24	Sale	240.01	1,126	270,252	27,013	Nov 12 10:48 AM
Schwenger Thomas D.	Director	Nov 08 '24	Proposed Sale	240.01	1,126	270,252		Nov 08 12:28 PM
Zuppas Eleni Nitsa	President & Chief of Staff	Oct 01 '24	Option Exercise	0.00	1,324	0	22,645	Oct 02 05:58 PM
Schwenger Thomas D.	Pres. & Chief Customer Officer	Oct 01 '24	Option Exercise	0.00	1,909	0	28,974	Oct 02 05:55 PM
DIAMOND KRISTINE	Chief Accounting Officer	Oct 01 '24	Option Exercise	0.00	204	0	692	Oct 02 05:54 PM
Faddis Jonathan	SVP, Gen. Counsel, Secretary	Oct 01 '24	Option Exercise	0.00	1,120	0	10,155	Oct 02 05:53 PM
Cabral Timothy S	Interim CFO	Sep 01 '24	Option Exercise	0.00	315	0	1,426	Sep 03 05:56 PM
Carges Mark T	Director	Sep 01 '24	Option Exercise	0.00	357	0	357	Sep 03 05:00 PM
Hedley Mary Lynne	Director	Sep 01 '24	Option Exercise	0.00	343	0	5,075	Sep 03 04:57 PM
Hung Priscilla	Director	Sep 01 '24	Option Exercise	0.00	343	0	3,281	Sep 03 04:56 PM
Hunt Nimrata	Director	Sep 01 '24	Option Exercise	0.00	343	0	3,174	Sep 03 04:55 PM
MOHR MARSHALL	Director	Sep 01 '24	Option Exercise	0.00	385	0	3,667	Sep 03 04:53 PM
Ritter Gordon	Director	Sep 01 '24	Option Exercise	0.00	399	0	1,102	Sep 03 04:52 PM
SEKHRI PAUL J	Director	Sep 01 '24	Option Exercise	0.00	329	0	15,683	Sep 03 04:51 PM
Wallach Matthew J	Director	Sep 01 '24	Option Exercise	0.00	329	0	104,934	Sep 03 04:49 PM
Faddis Jonathan	SVP, Gen. Counsel, Secretary	Aug 21 '24	Sale	200.00	2,353	470,600	9,035	Aug 21 05:10 PM
Faddis Jonathan	Officer	Aug 21 '24	Proposed Sale	200.00	2,353	470,600		Aug 21 04:27 PM
Epstein Stacey	Chief Marketing Officer	Jul 01 '24	Option Exercise	0.00	891	0	891	Jul 02 05:21 PM
Zuppas Eleni Nitsa	President & Chief of Staff	Jul 01 '24	Option Exercise	0.00	1,324	0	21,321	Jul 02 05:21 PM
Schwenger Thomas D.	Pres. & Chief Customer Officer	Jul 01 '24	Option Exercise	0.00	1,909	0	27,867	Jul 02 05:21 PM
DIAMOND KRISTINE	Chief Accounting Officer	Jul 01 '24	Option Exercise	0.00	204	0	561	Jul 02 05:21 PM
Faddis Jonathan	SVP, Gen. Counsel, Secretary	Jul 01 '24	Option Exercise	0.00	1,120	0	11,788	Jul 02 05:21 PM
Cabral Timothy S	Interim CFO	Jun 07 '24	Sale	184.33	15,000	2,764,931	8,391	Jun 07 05:53 PM
Hung Priscilla	Director	Jun 01 '24	Option Exercise	0.00	302	0	2,938	Jun 03 05:12 PM
Cabral Timothy S	Director	Jun 01 '24	Option Exercise	0.00	278	0	1,111	Jun 03 05:11 PM
Carges Mark T	Director	Jun 01 '24	Option Exercise	0.00	315	0	315	Jun 03 05:10 PM
Hedley Mary Lynne	Director	Jun 01 '24	Option Exercise	0.00	302	0	4,732	Jun 03 05:09 PM
Hunt Nimrata	Director	Jun 01 '24	Option Exercise	0.00	302	0	2,831	Jun 03 05:09 PM
MOHR MARSHALL	Director	Jun 01 '24	Option Exercise	0.00	339	0	3,282	Jun 03 05:08 PM
Ritter Gordon	Director	Jun 01 '24	Option Exercise	0.00	352	0	703	Jun 03 05:08 PM
SEKHRI PAUL J	Director	Jun 01 '24	Option Exercise	0.00	290	0	15,354	Jun 03 05:07 PM
Wallach Matthew J	Director	Jun 01 '24	Option Exercise	0.00	290	0	104,605	Jun 03 05:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VEEV

Veeva Systems Inc

Upgrade your FINVIZ experience